Founder's Dilemmas

The Making of a Star CFO, Part 2: Julie Feder’s Path from Sy Syms to a NASDAQ IPO

Charlie Harary and Noam Wasserman Season 2 Episode 10

Charlie Harary and Dean Noam Wasserman delve further into the aftermath of the IPO through which Julie Feder led Aura Biosciences, the challenges of career dedication and Julie’s solutions to those challenges, and finding meaning and impact through a career in finance.

Produced by Uri Westrich